US mortgage rates dip, but economists see volatility ahead
The average rate on a 30-year mortgage is still down from its 2024 high of 7.22% in May, but above a low of 6.08% in late ...
Trump's economic agenda for his second term is clouding the outlook for mortgage rates
Donald Trump’s election win is clouding the outlook for mortgage rates even before he gets back to the White House ...
The world’s 10 richest people got a record $64 billion richer following Trump’s reelection
The world's 10 richest people, led by Elon Musk, gained a record $64 billion in a day as markets rallied on investor ...
Baptist News Global3d
Trump pledges to bring back prayer in schools and offer ‘school choice’ everywhere
Trump’s 10-point plan echoes Project 2025 and fulfills a conservative wish list that includes dismantling the U.S. Department ...
Benchmarks end lower, Nifty ends below 24,150; Trent slides 3%
The domestic equity benchmarks concluded the trading session on a negative note on Friday, despite a positive global sentiment triggered by a 25 basis point rate cut by the US Federal Reserve. The ...
Business Insider6d
Moderna price target lowered to $111 from $125 at Barclays
Barclays lowered the firm’s price target on Moderna (MRNA) to $111 from $125 and keeps an Overweight rating on the shares. The company’s Q3 SpikeVax revenue beat estimates and guidance was ...
Business Insider4d
Maravai Lifesciences price target lowered to $7 from $10 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Maravai Lifesciences (MRVI) to $7 from $10 and keeps an Equal Weight rating on the shares following another miss and significant guidance cut.
Yahoo Finance5d
Maravai Lifesciences price target lowered to $9 from $10 at Baird
Baird analyst Catherine Schulte lowered the firm’s price target on Maravai Lifesciences (MRVI) to $9 from $10 and keeps an Outperform rating on the shares. The firm said they reported 3Q results ...